Key points are not available for this paper at this time.
The interim analysis of the PMS of adult patients with schizophrenia demonstrate the safety and effectiveness of lurasidone in the Chinese population. No new safety or efficacy concerns were identified.
Wei et al. (Fri,) studied this question.